Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Hansson

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Melanoma Research|April 23, 2005
Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locationsPeter Gillgren, Gudrun Brattström, Jan Frisell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2011
KIT pathway alterations in mucosal melanomas of the vulva and other sitesKatarina Omholt, Eva Grafström, Lena Kanter-Lewensohn, et al.
Clinical Epidemiology|June 17, 2016
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literatureFernanda Costa Svedman, Demetris Pillas, Aliki Taylor, et al.
International Journal of Cancer|February 3, 2005
Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cellsMalihe Eskandarpour, Shahryar Kiaii, Chaoyong Zhu, et al.
International Journal of Cancer|June 22, 2017
Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanomaDaniela Gordon, Johan Hansson, Sandra Eloranta, et al.
Journal of the American Academy of Dermatology|May 6, 2014
Risk of cutaneous malignant melanoma in patients with celiac disease: a population-based studyBenjamin Lebwohl, Hanna Eriksson, Johan Hansson, et al.
International Journal of Cancer|August 27, 2016
Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrenceJulia Rockberg, Justyna M Amelio, Aliki Taylor, et al.
The Laryngoscope|October 12, 2004
High-dose Cisplatin with amifostine: ototoxicity and pharmacokineticsAndreas Ekborn, Johan Hansson, Hans Ehrsson, et al.
Cancer Letters|August 15, 2002
A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARFJamileh Hashemi, Mikael S Lindström, Charlotte Asker, et al.
The Journal of Investigative Dermatology|August 21, 2021
Coexpression of MTH1 and PMS2 Is Associated with Advanced Disease and Disease Progression after Therapy in MelanomaIshani Das, Rainer Tuominen, Thomas Helleday, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Melanoma Research|April 23, 2005
Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locationsPeter Gillgren, Gudrun Brattström, Jan Frisell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2011
KIT pathway alterations in mucosal melanomas of the vulva and other sitesKatarina Omholt, Eva Grafström, Lena Kanter-Lewensohn, et al.
Clinical Epidemiology|June 17, 2016
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literatureFernanda Costa Svedman, Demetris Pillas, Aliki Taylor, et al.
International Journal of Cancer|February 3, 2005
Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cellsMalihe Eskandarpour, Shahryar Kiaii, Chaoyong Zhu, et al.
International Journal of Cancer|June 22, 2017
Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanomaDaniela Gordon, Johan Hansson, Sandra Eloranta, et al.
Journal of the American Academy of Dermatology|May 6, 2014
Risk of cutaneous malignant melanoma in patients with celiac disease: a population-based studyBenjamin Lebwohl, Hanna Eriksson, Johan Hansson, et al.
International Journal of Cancer|August 27, 2016
Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrenceJulia Rockberg, Justyna M Amelio, Aliki Taylor, et al.
The Laryngoscope|October 12, 2004
High-dose Cisplatin with amifostine: ototoxicity and pharmacokineticsAndreas Ekborn, Johan Hansson, Hans Ehrsson, et al.
Cancer Letters|August 15, 2002
A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARFJamileh Hashemi, Mikael S Lindström, Charlotte Asker, et al.
The Journal of Investigative Dermatology|August 21, 2021
Coexpression of MTH1 and PMS2 Is Associated with Advanced Disease and Disease Progression after Therapy in MelanomaIshani Das, Rainer Tuominen, Thomas Helleday, et al.
Pageof 20